221 related articles for article (PubMed ID: 19318497)
1. Expression of hepatocyte growth factor and its receptor met in Wilms' tumors and nephrogenic rests reflects their roles in kidney development.
Vuononvirta R; Sebire NJ; Messahel B; Perusinghe N; Reis-Filho JS; Pritchard-Jones K; Vujanic GM; Jones C
Clin Cancer Res; 2009 Apr; 15(8):2723-30. PubMed ID: 19318497
[TBL] [Abstract][Full Text] [Related]
2. Expression and localization of HGF and met in Wilms' tumours.
Alami J; Williams BR; Yeger H
J Pathol; 2002 Jan; 196(1):76-84. PubMed ID: 11748645
[TBL] [Abstract][Full Text] [Related]
3. Blastemal expression of type I insulin-like growth factor receptor in Wilms' tumors is driven by increased copy number and correlates with relapse.
Natrajan R; Reis-Filho JS; Little SE; Messahel B; Brundler MA; Dome JS; Grundy PE; Vujanic GM; Pritchard-Jones K; Jones C
Cancer Res; 2006 Dec; 66(23):11148-55. PubMed ID: 17145858
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
5. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors.
Natrajan R; Little SE; Reis-Filho JS; Hing L; Messahel B; Grundy PE; Dome JS; Schneider T; Vujanic GM; Pritchard-Jones K; Jones C
Clin Cancer Res; 2006 Dec; 12(24):7284-93. PubMed ID: 17189400
[TBL] [Abstract][Full Text] [Related]
6. Derivation and characterization of a Wilms' tumour cell line, WiT 49.
Alami J; Williams BR; Yeger H
Int J Cancer; 2003 Nov; 107(3):365-74. PubMed ID: 14506735
[TBL] [Abstract][Full Text] [Related]
7. PAX3 is expressed in the stromal compartment of the developing kidney and in Wilms tumors with myogenic phenotype.
Hueber PA; Fukuzawa R; Elkares R; Chu L; Blumentkrantz M; He SJ; Anaka MR; Reeve AE; Eccles M; Jabado N; Iglesias DM; Goodyer PR
Pediatr Dev Pathol; 2009; 12(5):347-54. PubMed ID: 18666806
[TBL] [Abstract][Full Text] [Related]
8. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.
Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE
Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125
[TBL] [Abstract][Full Text] [Related]
9. Deficient expression of mRNA for the putative inductive factor bone morphogenetic protein-7 in chemically initiated rat nephroblastomas.
Higinbotham KG; Karavanova ID; Diwan BA; Perantoni AO
Mol Carcinog; 1998 Oct; 23(2):53-61. PubMed ID: 9808158
[TBL] [Abstract][Full Text] [Related]
10. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
[TBL] [Abstract][Full Text] [Related]
11. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
13. Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset.
Maschietto M; Trapé AP; Piccoli FS; Ricca TI; Dias AA; Coudry RA; Galante PA; Torres C; Fahhan L; Lourenço S; Grundy PE; de Camargo B; de Souza S; Neves EJ; Soares FA; Brentani H; Carraro DM
Cell Death Dis; 2011 Nov; 2(11):e224. PubMed ID: 22048167
[TBL] [Abstract][Full Text] [Related]
14. Stromal β-catenin activation impacts nephron progenitor differentiation in the developing kidney and may contribute to Wilms tumor.
Drake KA; Chaney CP; Das A; Roy P; Kwartler CS; Rakheja D; Carroll TJ
Development; 2020 Jul; 147(21):. PubMed ID: 32541007
[TBL] [Abstract][Full Text] [Related]
15. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K; Fleming S
Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
[TBL] [Abstract][Full Text] [Related]
16. Stage-specific elevated expression of the genes for hepatocyte growth factor, keratinocyte growth factor, and their receptors during the morphogenesis and differentiation of rat stomach mucosa.
Matsubara Y; Ichinose M; Tatematsu M; Ichinose M; Oka M; Yahagi N; Kurokawa K; Kageyama T; Miki K; Fukamachi H
Biochem Biophys Res Commun; 1996 May; 222(3):669-77. PubMed ID: 8651903
[TBL] [Abstract][Full Text] [Related]
17. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development.
Sonnenberg E; Meyer D; Weidner KM; Birchmeier C
J Cell Biol; 1993 Oct; 123(1):223-35. PubMed ID: 8408200
[TBL] [Abstract][Full Text] [Related]
18. Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.
Navab R; Liu J; Seiden-Long I; Shih W; Li M; Bandarchi B; Chen Y; Lau D; Zu YF; Cescon D; Zhu CQ; Organ S; Ibrahimov E; Ohanessian D; Tsao MS
Neoplasia; 2009 Dec; 11(12):1292-300. PubMed ID: 20019837
[TBL] [Abstract][Full Text] [Related]
19. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE
Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
[TBL] [Abstract][Full Text] [Related]
20. Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition.
Li CM; Guo M; Borczuk A; Powell CA; Wei M; Thaker HM; Friedman R; Klein U; Tycko B
Am J Pathol; 2002 Jun; 160(6):2181-90. PubMed ID: 12057921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
